309 related articles for article (PubMed ID: 28039457)
1. Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22-CCR4 axis.
Maolake A; Izumi K; Shigehara K; Natsagdorj A; Iwamoto H; Kadomoto S; Takezawa Y; Machioka K; Narimoto K; Namiki M; Lin WJ; Wufuer G; Mizokami A
Oncotarget; 2017 Feb; 8(6):9739-9751. PubMed ID: 28039457
[TBL] [Abstract][Full Text] [Related]
2. Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma.
Tsujikawa T; Yaguchi T; Ohmura G; Ohta S; Kobayashi A; Kawamura N; Fujita T; Nakano H; Shimada T; Takahashi T; Nakao R; Yanagisawa A; Hisa Y; Kawakami Y
Int J Cancer; 2013 Jun; 132(12):2755-66. PubMed ID: 23180648
[TBL] [Abstract][Full Text] [Related]
3. CCL17 and CCL22 induce CCR4 receptor expression and promote cytokine-induced killer cells migration.
Dong Y; Gao S; Zhang X; Kou J; Liu J; Ye T; Shen H
Anticancer Drugs; 2022 Feb; 33(2):149-157. PubMed ID: 34657098
[TBL] [Abstract][Full Text] [Related]
4. Expression of chemokine receptor CCR4 and its ligands (CCL17 and CCL22) in murine contact hypersensitivity.
Kusumoto M; Xu B; Shi M; Matsuyama T; Aoyama K; Takeuchi T
J Interferon Cytokine Res; 2007 Nov; 27(11):901-10. PubMed ID: 18052724
[TBL] [Abstract][Full Text] [Related]
5. CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma.
Kumai T; Nagato T; Kobayashi H; Komabayashi Y; Ueda S; Kishibe K; Ohkuri T; Takahara M; Celis E; Harabuchi Y
Cancer Immunol Immunother; 2015 Jun; 64(6):697-705. PubMed ID: 25754123
[TBL] [Abstract][Full Text] [Related]
6. CCL17 acts as an antitumor chemokine in micromilieu-driven immune skewing.
Li Y; Cao H; Jiang Z; Yan K; Shi J; Wang S; Wang F; Wang W; Li X; Sun N; Liu L; Chen L; Chen Y; Guo R; Song Y
Int Immunopharmacol; 2023 May; 118():110078. PubMed ID: 37001380
[TBL] [Abstract][Full Text] [Related]
7. Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling.
Han R; Gu S; Zhang Y; Luo A; Jing X; Zhao L; Zhao X; Zhang L
Sci Rep; 2018 Jun; 8(1):9575. PubMed ID: 29934505
[TBL] [Abstract][Full Text] [Related]
8. Engagement of two distinct binding domains on CCL17 is required for signaling through CCR4 and establishment of localized inflammatory conditions in the lung.
Santulli-Marotto S; Boakye K; Lacy E; Wu SJ; Luongo J; Kavalkovich K; Coelho A; Hogaboam CM; Ryan M
PLoS One; 2013; 8(12):e81465. PubMed ID: 24339934
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of Th2 chemokine receptors on T cells from atopic and nonatopic asthmatics in response to Der p 1-pulsed dendritic cells.
Maneechotesuwan K; Wongkajornsilp A; Huabprasert S; Kasetsinsombat K; Suthumansami T
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S62-70. PubMed ID: 20364559
[TBL] [Abstract][Full Text] [Related]
10. The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer.
Li JY; Ou ZL; Yu SJ; Gu XL; Yang C; Chen AX; Di GH; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2012 Feb; 131(3):837-48. PubMed ID: 21479551
[TBL] [Abstract][Full Text] [Related]
11. Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis.
Yogo Y; Fujishima S; Inoue T; Saito F; Shiomi T; Yamaguchi K; Ishizaka A
Respir Res; 2009 Aug; 10(1):80. PubMed ID: 19715610
[TBL] [Abstract][Full Text] [Related]
12. Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells.
Mariani M; Lang R; Binda E; Panina-Bordignon P; D'Ambrosio D
Eur J Immunol; 2004 Jan; 34(1):231-40. PubMed ID: 14971049
[TBL] [Abstract][Full Text] [Related]
13. The role of the Th2 CC chemokine ligand CCL17 in pulmonary fibrosis.
Belperio JA; Dy M; Murray L; Burdick MD; Xue YY; Strieter RM; Keane MP
J Immunol; 2004 Oct; 173(7):4692-8. PubMed ID: 15383605
[TBL] [Abstract][Full Text] [Related]
14. Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17.
Zhang A; Xu Y; Xu H; Ren J; Meng T; Ni Y; Zhu Q; Zhang WB; Pan YB; Jin J; Bi Y; Wu ZB; Lin S; Lou M
Theranostics; 2021; 11(8):3839-3852. PubMed ID: 33664865
[No Abstract] [Full Text] [Related]
15. Paracrine CCL17 and CCL22 signaling regulates hematopoietic stem/progenitor cell migration and retention in mouse fetal liver.
Konno K; Sasaki T; Kulkeaw K; Sugiyama D
Biochem Biophys Res Commun; 2020 Jun; 527(3):730-736. PubMed ID: 32439173
[TBL] [Abstract][Full Text] [Related]
16. CCL17 and CCL22 attenuate CCL5-induced mast cell migration.
Juremalm M; Olsson N; Nilsson G
Clin Exp Allergy; 2005 Jun; 35(6):708-12. PubMed ID: 15969658
[TBL] [Abstract][Full Text] [Related]
17. The CCL17-CCR4 axis between endometrial stromal cells and macrophages contributes to the high levels of IL-6 in ectopic milieu.
Zhou WJ; Hou XX; Wang XQ; Li DJ
Am J Reprod Immunol; 2017 Aug; 78(2):. PubMed ID: 28240436
[TBL] [Abstract][Full Text] [Related]
18. Distinct conformations of the chemokine receptor CCR4 with implications for its targeting in allergy.
Viney JM; Andrew DP; Phillips RM; Meiser A; Patel P; Lennartz-Walker M; Cousins DJ; Barton NP; Hall DA; Pease JE
J Immunol; 2014 Apr; 192(7):3419-27. PubMed ID: 24563252
[TBL] [Abstract][Full Text] [Related]
19. RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4.
Nakamura ES; Koizumi K; Kobayashi M; Saitoh Y; Arita Y; Nakayama T; Sakurai H; Yoshie O; Saiki I
Clin Exp Metastasis; 2006; 23(1):9-18. PubMed ID: 16821125
[TBL] [Abstract][Full Text] [Related]
20. Role of CCR4 ligands, CCL17 and CCL22, during Schistosoma mansoni egg-induced pulmonary granuloma formation in mice.
Jakubzick C; Wen H; Matsukawa A; Keller M; Kunkel SL; Hogaboam CM
Am J Pathol; 2004 Oct; 165(4):1211-21. PubMed ID: 15466387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
